Clinical Trial

A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD

Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate the effect of CS reducer implantation in patients with HFPEF and CMD on myocardial ischemia, measured by stress myocardial perfusion using cardiovascular magnetic resonance (CMR)
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-07-23; most recent amendment 2026-02-24.
Status change: Enrolling by Invitation → Recruiting 2026-02-24
Status change: Recruiting → Enrolling by Invitation 2025-11-25
Status change: Not Yet Recruiting → Recruiting 2025-09-22
Trial Details
NCT Number NCT07093528
Lead Sponsor Mayo Clinic
Conditions Heart Failure With Preserved Ejection Fraction, Coronary Microvascular Dysfunction
Enrollment 25 participants
Start Date 2025-10-16
Primary Completion 2027-08 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-02-27